FK506, an immunosuppressant targeting calcineurin function.
about
The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesisInteraction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): effects of FK506Phage p1-derived artificial chromosomes facilitate heterologous expression of the FK506 gene clusterC-terminal Src kinase controls development and maintenance of mouse squamous epithelia.A general approach for chemical labeling and rapid, spatially controlled protein inactivation.Towards a proteomic analysis of atopic dermatitis: a two-dimensional-polyacrylamide gel electrophoresis/mass spectrometric analysis of cultured patient-derived fibroblasts.Caerulein-induced intracellular pancreatic zymogen activation is dependent on calcineurin.Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo.Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucomaDrug therapy of primary biliary diseases: classical and modern strategies.FK506-binding protein 12 ligands: a patent review.Inhibition of calcineurin facilitates the induction of memory for sensitization in Aplysia: requirement of mitogen-activated protein kinaseHuman herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat.Viewing serine/threonine protein phosphatases through the eyes of drug designersRegulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52).Tissue-specific expression of human calcineurin-binding protein 1 in mouse synovial tissue can suppress inflammatory arthritis.The mode of topical immunomodulators in the immunological network of atopic dermatitis.Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies.Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?Loss of stem cell regenerative capacity within aged nichesPolymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.Therapeutic targeting of the inflammome.Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytesSelective role of calcineurin in haematopoiesis and lymphopoiesis.Ascomycin and FK506: pharmacology and therapeutic potential as anticonvulsants and neuroprotectants.Characterization of a Bcl-XL-interacting protein FKBP8 and its splice variant in human RPE cells.Protease activation during in vivo pancreatitis is dependent on calcineurin activation.The Function of FK506-Binding Protein 13 in Protein Quality Control Protects Plasma Cells from Endoplasmic Reticulum Stress-Associated Apoptosis.Neurocognitive-neurological complications of liver transplantation: a review.FKBP immunophilins and Alzheimer's disease: a chaperoned affair.The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.MicroRNA expression analysis during FK506-induced osteogenic differentiation in rat bone marrow stromal cellsRecent advances in connective tissue disease related interstitial lung disease.Tacrolimus Modulates TGF-β Signaling to Induce Epithelial-Mesenchymal Transition in Human Renal Proximal Tubule Epithelial CellsFunctional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis.Successful treatment of cyclosporine-A-resistant cytophagic histiocytic panniculitis with tacrolimus.Protective effect of Korean Red Ginseng against FK506-induced damage in LLC-PK1 cells.Synthesis of orthogonally reactive FK506 derivatives via olefin cross metathesis.
P2860
Q24295283-FD0576B4-88EF-4AA9-8D43-FE5EC1B87394Q24553749-A24A319E-079D-47DF-9EFA-624F1CB7CEB1Q28534635-8360717E-AF33-4B11-BF34-0A7B6EFC446CQ30479068-8FF17EC5-B22D-44B5-ABD2-E8B9BC19E3F9Q33204222-F2071B19-B677-4090-B541-7DE32D6C24DAQ33207680-8E065DA0-FB24-4D3B-B760-E7AFEBDBA48DQ33276374-9A0115ED-DF59-4A05-9B04-AB0E6255A65AQ33890996-18E6C3AC-1DD3-45DE-B2BD-6EDD58EB0CB1Q33917505-2E91C579-C394-4C61-A1DD-0838B3A290A5Q34687676-F914F1F4-BFC6-40EA-AF03-0BF05F020F64Q34955459-29F6174C-7143-4ACE-9A32-1B904CA934BBQ34961244-919379A1-1403-4142-B8FC-F57C7487A32CQ34976938-D2F75651-83ED-43DB-B013-7F0AD0CE0FFBQ35146774-530537A8-0940-41DF-AF4B-D64BC29B3114Q35165175-829C2227-B528-4E8F-BA5B-F391CC3C9F34Q35664985-7DEF984C-5E08-41E0-8366-4D5D7530535DQ36051518-9729D091-A4C7-4D32-B4CC-CEB3D7118C58Q36102839-CDEF602D-DF82-4CF7-9970-7DC604638DFDQ36111849-89DB2E5F-76CA-45A7-9058-991F2C2323AEQ36117006-C1D13A7E-6577-46E2-B91E-98754AC22677Q36287545-25419AFF-DE17-43F6-9EBF-8AC092946314Q36490256-AD46407D-A933-464A-82A8-AD1734CF8249Q36508895-0EE95DF4-E653-46EA-8655-B1A9E45FAC06Q36969291-DFD6692C-A350-49B7-9504-2A7EDEB407D5Q37164694-37F9AF7C-C49A-4B78-98AD-980FEFDE3CE3Q37273435-C8612587-A198-4F43-B1BD-5FB5D44832A5Q37421161-9FF23B0A-4AFD-47B1-B3FF-FF7370A490E1Q37675354-EA7AC37B-9175-4E49-A78E-819C412B8525Q37702869-3D8095A4-84D3-43D4-A982-C03856EB3F8CQ37907734-9CAC63C7-82D8-493B-8F3B-D79274DB3185Q38258248-C28C8AE3-83E4-40FC-9D8E-BA4488AF574AQ38432986-7FDE62A8-4DFA-415F-8510-343C3AB4F066Q38678939-F1F094F6-F0AA-411A-A90C-1657298C3413Q38774503-030AA72F-2281-47C8-A55D-695175964FCFQ39746465-36682112-24E4-4BA8-A5A9-655E30BDD4F7Q39805013-60F17279-4967-44BD-8331-C13C2841E539Q39885707-FE76328E-E92D-4C08-A0AC-607095A5C32FQ40331807-74786276-8FBC-428A-9654-A4DB7E40EE6BQ41009926-75F2DEEB-669D-46DD-BC94-B966A71DE4BEQ41790826-0C7327D4-92D5-40CD-8ABE-78A294B3E80B
P2860
FK506, an immunosuppressant targeting calcineurin function.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
FK506, an immunosuppressant targeting calcineurin function.
@ast
FK506, an immunosuppressant targeting calcineurin function.
@en
type
label
FK506, an immunosuppressant targeting calcineurin function.
@ast
FK506, an immunosuppressant targeting calcineurin function.
@en
prefLabel
FK506, an immunosuppressant targeting calcineurin function.
@ast
FK506, an immunosuppressant targeting calcineurin function.
@en
P356
P1476
FK506, an immunosuppressant targeting calcineurin function.
@en
P2093
P304
P356
10.2174/0929867003374723
P577
2000-07-01T00:00:00Z